Lv1
34 积分 2024-09-06 加入
Lysyl oxidase-like 2 (LOXL2) comme cible d’imagerie pour la quantification et le suivi de la progression de la fibrose pulmonaire expérimentale
15小时前
已关闭
A phase II randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of simtuzumab (GS-6624) combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma
2天前
已关闭
Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression
2天前
已完结
Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients
3天前
已完结
Biomarkers and Surrogate Endpoints: Developing Common Terminology and Definitions
3天前
已完结
Hepatic inflammatory responses in liver fibrosis
3天前
已完结
Screening for liver fibrosis: lessons from colorectal and lung cancer screening
3天前
已完结
A mark is a marker
4天前
已完结
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
4天前
已完结
In vivo ultrasound-induced luminescence imaging via trianthracene derivatives nanomaterials
16天前
已完结
皖公网安备34019202002308
